BHST BioHarvest Sciences Inc. Common Stock
Basic Materials$3.91+1.30%ClosedMarket Cap: $67.8M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
3.80
P/S
1.90
EV/EBITDA
-9.60
DCF Value
$-259.44
FCF Yield
-14.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
59.5%
Operating Margin
-16.2%
Net Margin
-32.5%
ROE
-88.0%
ROA
-25.1%
ROIC
-14.4%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $8.5M | 59.2% | $-1.8M | $-2.6M | $— | — |
| Q4 null | $9.1M | 57.6% | $-1.1M | $-2.2M | $— | — |
| FY null | $34.5M | 59.3% | $-5.6M | $-11.1M | $— | — |
| Q3 null | $9.1M | 61.4% | $-920.0K | $-2.5M | $— | — |
| Q2 null | $8.5M | 59.7% | $-1.8M | $-4.1M | $— | — |
| Q1 null | $7.9M | 58.5% | $-1.7M | $-2.3M | $— | — |
| Q4 null | $7.3M | 56.7% | $-1.7M | $-3.0M | $— | — |
| FY null | $25.2M | 55.4% | $-7.0M | $-12.9M | $— | — |
| Q3 null | $6.5M | 56.8% | $-2.1M | $-2.7M | $— | — |
| Q2 null | $6.0M | 51.5% | $-1.8M | $-687.0K | $— | — |
| Q1 null | $5.3M | 56.2% | $-1.4M | $-6.6M | $— | — |
| Q4 2023 | $4.5M | 50.7% | $-2.5M | $-7.2M | $-0.54 | — |